jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.
bi accounts
.
advertisement
.
.
.
another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict
.
china is host to 70 percent of all car cell therapy trials registered in 2017 and the first four months of 2018 (150 out of 214).
.
he added: �these findings show that despite the tireless work of doctors and nurses, it appears that some cancer patients are still enduring shockingly long waits to start treatment.
.
.
gelfand noted the impact on hdl may be balanced by the improvement seen in markers of
.